Plus: eGenesis, the startup behind the first pig-human kidney transplant, is targeting hearts and livers next. : Plus: eGenesis, the startup behind the first pig-human kidney transplant, is targeting hearts and livers next. As a postdoctoral researcher at the Broad Institute of MIT and Harvard, Nicole Gaudelli was the co-inventor of a breakthrough in gene editing: the ability to target a single misspelling in DNA code. This invention, known as base editing, is a further advancement of the Nobel Prize-winning Crispr technology and has the potential to cure thousands of rare diseases caused by point mutations.